Filed under: News
Insidevaccines will be posting occasional news stories related to vaccines with commentary by our team of editors. Here we go–
In 2002 Robert Goldberg wrote:
Despite significant activity in the area of vaccine design, vaccinology and immunology, vaccine development is on the verge of becoming a brackish backwater of other biotechnology and pharmaceutical enterprises. The market for vaccines is dominated by government purchasers that drive prices down to commodity levels, the regulations for the development and production of new vaccines are mired in the 1950s and sometimes cost more than producing vaccines themselves.
Public health officials and politicians are — depending on the day — either indifferent or outright hostile to the [sic] providing private companies with incentives for investing in new vaccines for a wide range of diseases. Indeed the solution de jour is to have the government — perhaps the Department of Defense (DOD) or some offshoot of the public health service — take over the development and production of vaccines, as if a U.S. government run National Vaccine Authority could magically and efficiently construct and operate billion dollar facilities without any glitches or major disruptions. Only scientists whose only brush with business is food shopping could concoct such an idiotic scheme.
Those of us used to trawling medical literature have long since come to the view that disease prevalence rates used to justify a vaccine’s introduction, have about as much credibility as a self-combusted crystal ball. The numbers quoted are usually imaginatively inflated, or a result of appallingly badly designed studies. This has been a provable pattern since statistical sculpturing tactics, which were used to inflate polio infection data during the 1950’s, were first revealed in 1960 (PMID 13857182). With previous jury-rigging in mind, the recent announcement that the number of AIDS cases in India, is only half of the earlier estimates, came as no surprise. Neither were we surprised to find that when the formula which the CDC used to over-inflate the numbers of hepatitis B cases in India was asked for, the CDC had to admit that it had gone “missing”. (PMID 15547938) Also, while the WHO used to advise mass vaccination for hepatitis B if the prevalence was more than 2 per 100, that advice has been dropped in favour of mass vaccination everywhere, regardless of disease incidence.
Scene: A pediatrician’s office. Behind the desk is the doctor, a pleasant, middle-aged woman in a white coat. Seated in front of the desk are the expectant parents, prosperous, educated, self-confident, and, in the case of the woman, exceedingly pregnant.
Doctor: So, what questions did you have for me today?
Mother: We are concerned about the current vaccine schedule.* We know that babies should be protected from serious diseases, but the current schedule is getting…well, strange. (Pulls a scroll from her purse and starts unwinding it, reading off the schedule as she goes, and inserting comments) So, at birth, they want our baby to get a Hepatitis B vaccination. We both test negative and are not at risk for that disease.
Father: Does our baby really need that one?
A child gets vaccinated and is from that moment on protected from the vaccine virus, correct? We all realize that vaccines are not 100% failproof, but is that the only concern?
If it only were that simple. The fact is that once a child is injected with a live virus vaccine (and let’s assume that this child is immune as a result of it) there are still other things to consider which most parents do not know about and most pediatricians fail to warn about – which is vaccine shedding!